Latest News About Projectpuma

Updated 2026-05-21 06:06

I don’t currently have live access to authoritative updates on a project named “ProjectPuma.” If you can share a bit more context (for example, which company or domain this project belongs to, or a link to a official press release), I can summarize the latest information or help you monitor developments.

If you’d like, I can:

Would you like me to proceed with a targeted search for recent public updates on Puma Biotechnology or another organization associated with “ProjectPuma”? If you have a URL or region of interest (e.g., U.S. FDA updates, EU approvals), share it and I’ll tailor the briefing.

Sources

Puma | The Independent

The latest breaking news, comment and features from The Independent.

www.independent.co.uk

Pumas

Read the latest UK headlines, on NewsNow. UK news, analysis and opinion from around the world.

www.newsnow.co.uk

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Neratinib is a...

www.pumabiotechnology.com

Press Release Distribution and Management

GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.

www.globenewswire.com